In a 155-page lawsuit, Cleveland leaders accused numerous retail pharmacies, drugmakers and pharmacy benefit managers of hiking insulin prices that they said cost the city millions of dollars, according to court documents.
Read the full post on Becker's Hospital Review - Healthcare News
